AC Immune S.A.

NASDAQ: ACIU · Real-Time Price · USD
2.15
0.02 (0.94%)
At close: Aug 15, 2025, 3:59 PM
2.12
-1.17%
After-hours: Aug 15, 2025, 04:45 PM EDT

AC Immune S.A. Cash Flow Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-50.92M -54.23M -70.75M -73M
Depreciation & Amortization
2.16M 2.21M 2.36M 2.41M
Stock-Based Compensation
5.47M 4.37M 3.33M 4.13M
Other Working Capital
93.96M -360K -8.47M 6.94M
Other Non-Cash Items
1.61M 2.4M -72K -6.2M
Deferred Income Tax
n/a n/a n/a 130K
Change in Working Capital
107.51M -15.16M -8.43M 6.84M
Operating Cash Flow
65.84M -60.41M -73.57M -65.69M
Capital Expenditures
-576K -801K -1.24M -2.63M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-104.71M 66.45M 25M -51.03M
Investing Cash Flow
-105.29M 65.64M 23.76M -53.66M
Debt Repayment
-683K -548K -569K 22.95M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-548K n/a -776K -6K
Financial Cash Flow
-1.12M 43.25M -1.35M 40.75M
Net Cash Flow
-42.22M 46.91M -50.63M -78.68M
Free Cash Flow
65.27M -61.21M -74.81M -68.32M